# US 2008/0286775 A1 · Methods of nonspecific target capture of nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0286775 A1
- Document ID: US20080286775A1
- Status: Published application
- Kind: A1
- Application number: 11/832,367
- Filed: 2007-08-01
- Published: 2008-11-20
- Earliest claimed: 2006-08-01
- Assignees: Gen-Probe Incorporated
- Inventors: Michael M. BECKER; Mehrdad R. MAJLESSI
- Web page: https://patentgrep.com/patent/US20080286775A1

## CPC

- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C07H 21/02: with ribosyl as saccharide radical
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- C12N 2310/18: acting by a non-sequence specific mechanism
- C12N 2310/31: of the backbone
- C12N 2310/321: 2'-O-R Modification
- C12N 2310/351: Conjugate
- C12N 2330/30: chemically synthesised
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods for capturing a target nucleic acid from a sample by using a capture probe that binds nonspecifically to the target nucleic acid and binds specifically to an immobilized probe via a specific binding pair that has one member on the capture probe and one member on the immobilized probe are disclosed. Compositions that include a capture probe that binds nonspecifically to a target nucleic acid and specifically to an immobilized probe via binding of members of a specific binding pair in a solution phase of a reaction mixture are disclosed.

## Claims

### Claim 1

A method for isolating a target nucleic acid from a sample, comprising:
mixing a sample containing a target nucleic acid with a nonspecific capture probe made up of an oligonucleotide sequence that hybridizes nonspecifically with the target nucleic acid and a means for linking the target nucleic acid to a support, wherein the oligonucleotide sequence is selected from the group consisting of:
a poly-U sequence,
a random poly-(k) sequence comprising G and T nucleotides or G and U nucleotides, two random oligonucleotide sequences separated by a non-random sequence consisting of 10 or fewer nucleotides,
two random oligonucleotide sequences separated by a non-random sequence consisting of 10 or fewer nucleotide base analogs,
two random oligonucleotide sequences separated by a non-nucleotide spacer compound, a plurality of random oligonucleotide sequences separated by non-random sequences consisting of 10 or fewer nucleotides or nucleotide base analogs, a plurality of random oligonucleotide sequences separated by non-nucleotide spacer compounds, and
a non-random poly-GU sequence made up of at least two GU units, incubating a reaction mixture containing the support, the target nucleic acid, and the nonspecific capture probe in hybridization conditions that allow nonspecific hybridization of the capture probe and the target nucleic acid to form a hybridization complex linked to the support, and
separating the support from a solution phase of the reaction mixture to separate the hybridization complex linked to the support from other sample components, thereby isolating the target nucleic acid from other sample components.

### Claim 2 (depends on 1)

The method of claim 1 wherein the means for linking the target nucleic acid to the support is direct attachment of the capture probe to the support.

### Claim 3 (depends on 1)

The method of claim 1 wherein the means for linking the target nucleic acid to the support is a specific binding pair made up of a first specific binding partner (SBP) attached to the capture probe that binds specifically to a second specific binding partner (SBP′) that is linked to the support.

### Claim 4 (depends on 3)

The method of claim 3 wherein the SBP′ is part of an immobilized probe that is linked to the support.

### Claim 5 (depends on 3)

The method of claim 3 wherein the mixing step includes mixing the sample with the SBP attached to the capture probe and the SBP′ linked to the support, and the incubating step includes binding the SBP and the SBP′ to link the hybridization complex to the support.

### Claim 6 (depends on 3)

The method of claim 3 wherein the SBP and the SBP′ are substantially complementary nucleic acid sequences.

### Claim 7 (depends on 3)

The method of claim 3 wherein the SBP and the SBP′ are non-nucleic acid moieties.

### Claim 8 (depends on 7)

The method of claim 7 wherein the non-nucleic acid moieties are selected from the group consisting of:
(a) a receptor and ligand pair, (b) an enzyme and substrate pair, (c) an enzyme and cofactor pair, (d) an enzyme and coenzyme pair, (e) an antibody and antigen pair, (f) an antibody fragment and antigen pair, (g) a sugar and lectin pair, (h) a ligand and chelating agent pair, (i) biotin and avidin, (j) biotin and streptavidin, and (k) nickel and histidine.

### Claim 9 (depends on 1)

The method of claim 1 further comprising a washing step after the separating step to remove other sample components from the hybridization complex linked to the support, wherein the washing step mixes the hybridization complex linked to the support with a washing solution and then separates the hybridization complex linked to the support from the washing solution.

### Claim 10 (depends on 1)

The method of claim 1 wherein the incubating step is performed at about 25° C. for about 5 minutes to about 90 minutes.

### Claim 11 (depends on 1)

The method of claim 1 further comprising a step after the separating step of detecting the presence of the target nucleic acid isolated from other sample components, amplifying in vitro a sequence contained in the target nucleic acid isolated from other sample components, or determining a sequence contained the target nucleic acid isolated from other sample components.

### Claim 12

A nonspecific capture probe comprising a first specific binding partner (SBP) that binds specifically to a second specific binding partner (SBP′) linked to a support and an oligonucleotide sequence that hybridizes nonspecifically to a target nucleic acid, wherein the oligonucleotide sequence is selected from the group consisting of:
a poly-U sequence,
a random poly-(k) sequence comprising G and T nucleotides or G and U nucleotides,
two random oligonucleotide sequences separated by a non-random sequence consisting of 10 or fewer nucleotides,
two random oligonucleotide sequences separated by a non-random sequence consisting of 10 or fewer nucleotide base analogs,
a plurality of random oligonucleotide sequences separated by non-random sequences consisting of 10 or fewer nucleotides or nucleotide base analogs,
two random oligonucleotide sequences separated by a non-nucleotide spacer compound,
a plurality of random oligonucleotide sequences separated by non-nucleotide spacer compounds, and
a non-random poly-GU sequence made up of at least two GU units.

### Claim 13 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence of about 5 to 100 nucleotides in length.

### Claim 14 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence of about 12 to about 25 nucleotides in length.

### Claim 15 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence contains: (a) standard RNA bases and linkages, (b) standard DNA bases and linkages, (c) RNA bases with 2′ modified linkages, (d) DNA bases in which at least part of the sequence is in a locked nucleic acid (LNA) conformation, (e) one or more nucleotide base analogs, (f) one or more abasic residues, (g) one or more non-nucleic acid spacer compounds, or (h) a combination of elements selected from groups (a) to (g) above.

### Claim 16 (depends on 15)

The capture probe of claim 15 wherein the base analogs exhibit alternative base pairing properties compared to standard DNA or RNA base pairing.

### Claim 17 (depends on 16)

The capture probe of claim 16 wherein the base analogs are inosine or 5-nitroindole.

### Claim 18 (depends on 15)

The capture probe of claim 15 wherein the oligonucleotide sequence contains a mixture of nucleotides in LNA conformation and standard DNA conformation.

### Claim 19 (depends on 15)

The capture probe of claim 15 wherein poly(k) bases are the RNA bases with 2′ modified linkages.

### Claim 20 (depends on 12)

The capture probe of claim 12 wherein the SBP that binds specifically to the SBP′ is a member of a specific binding pair selected from the group consisting of: (a) a pair of complementary nucleic acid sequences, (b) a receptor and ligand pair, (c) an enzyme and substrate pair, (d) an enzyme and cofactor pair, (e) an enzyme and coenzyme pair, (t) an antibody and antigen pair, (g) an antibody fragment and antigen pair, (h) a sugar and lectin pair, (i) a ligand and chelating agent pair, (j) biotin and avidin, (k) biotin and streptavidin, and (l) nickel and histidine.

### Claim 21 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence is linked to the SBP at a 5′ terminal position of the oligonucleotide, a 3′ terminal position of the oligonucleotide, or at an internal position of the oligonucleotide via a linker compound.

### Claim 22 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence comprises at least one random poly-(k)6 sequence.

### Claim 23 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence comprises a random poly-(k)12, poly-(k)18, or poly-(k)25 sequence.

### Claim 24 (depends on 12)

The capture probe of claim 12 wherein the oligonucleotide sequence is selected from the group consisting of:
(n)6-U3-(n)6,
(n)6-Ni5-(n)6 in which “Ni” stands for 5-nitroindole,
(k)6-Ni5-(k)6 in which “Ni” stands for 5-nitroindole,
(k)6-C9-C9-(k)6 in which “C9” stands for a 9 carbon non-nucleotide spacer,
(k)6-C9-(k)6-C9-(k)6 in which “C9” stands for a 9 carbon non-nucleotide spacer,
(k)12,
(k)6-U3-(k)6,
(k)6-U6-(k)6,
(k)6-T3-(k)6,
(k)18,
(k)24,
d(G or T)18,
L(k)6-dT3-L(k)6,
L(k)4-d(k)2-dT3-L(k)4-d(k)2,
U18,
L(k)4-d(k)3-L(k)4-d(k)3-L(k)4,
L(k)3-d(k)3-L(k)3-d(k)3-L(k)3-d(k)3,
(GU)9,
L(k)6-dT3-L(k)6,
L(k)4-d(k)2-dT3-L(k)4-d(k)2,
L(k)2-d(k)4-L(k)2-d(k)4-L(k)2-d(k)4,
d(k)6-dT3-L(k)6, and
L(k)4-d(k)3-L(k)4-d(k)3-L(k)4-d(k)3-L(k)4.

### Claim 25 (depends on 24)

The capture probe of claim 24 wherein the oligonucleotide sequence is joined to a homopolymeric nucleic acid sequence that is the SBP.
